Intervention
Continuous glucose monitoring system
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 10 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
10 shownContinuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal DialysisNCT07790276 · 2026-08-31
NOT_YET_RECRUITINGCGM in Icodextrin PDNCT06838819 · 2025-02-20
NOT_YET_RECRUITINGCharacterization of the "Transfusion-dependent Prediabetes" Using Continuous Glucose MonitoringNCT06533618 · 2023-07-01
COMPLETEDEvaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal DialysisNCT04776811 · 2021-03-01
COMPLETEDAssessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose LevelsNCT04031599 · 2020-07-10
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 DiabetesNCT02846831 · 2019-01-24
COMPLETEDComparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose LevelsNCT03335501 · 2018-04-01
WITHDRAWNClosed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 DiabetesNCT02488616 · 2018-03-01
WITHDRAWNPRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and AlgorithmNCT03251079 · 2017-07-25
COMPLETEDClosed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 DiabetesNCT02846857
WITHDRAWNCommon conditions
Type 1 Diabetes4Continuous Glucose Monitoring2Diabetes Mellitus (Diagnosis)2Dialysis2Diabetes Mellitus1Diabetes Mellitus (DM)1Diabetes Mellitus, Type 11Diabetes Mellitus, Type 21End Stage Renal Disease1End Stage Renal Disease (ESRD)1ESRD (End-Stage Renal Disease)1Peritoneal Dialysis (PD)1Prediabetic State1Type 1 Diabetes Mellitus1
Leading sponsors
Trial status mix
COMPLETED5
WITHDRAWN3
NOT_YET_RECRUITING2
Phase mix
PHASE24
NA3
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.